Botulinum neurotoxin for the treatment of movement disorders: Practical considerations
Botulinum neurotoxin (BoNT), produced by spore-forming anaerobic bacteria, is the most potent biological toxin and is a powerful therapeutic tool for several clinical indications in neurology and beyond. BoNT inhibits the release of acetylcholine from the presynaptic terminals of the neuromuscular j...
Main Authors: | Ajith Cherian, Asish Vijayaraghavan, Divya KP, Syam Krishnan |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2022-01-01
|
Series: | Annals of Movement Disorders |
Subjects: | |
Online Access: | http://www.aomd.in/article.asp?issn=2590-3446;year=2022;volume=5;issue=1;spage=38;epage=48;aulast=Cherian |
Similar Items
-
Use of Botulinum Neurotoxin in Ophthalmology
by: Emel Başar, et al.
Published: (2016-12-01) -
Outcomes of a regional variant of botulinum toxin type A in the treatment of essential blepharospasm and hemifacial spasms: A retrospective study
by: V Maneksha, et al.
Published: (2021-01-01) -
Toxina botulínica no blefaroespasmo, no espasmo hemifacial e na distonia cervical: resultados em 33 pacientes Botulinum toxin in blepharospasm, hemifacial spasm and cervical dystonia: results in 33 patients
by: Sérgio Ap. Novis, et al.
Published: (1995-09-01) -
Frequency of Hemorrhagic Side Effects of Botulinum Neurotoxin Treatment in Patients with Blepharospasm and Hemifacial Spasm on Antithrombotic Medication
by: Fiona Carolin Wenninger, et al.
Published: (2022-11-01) -
Effective treatment of hemifacial spasm and blepharospasm with botulinum toxin type A in Songklanagarind Hospital
by: S Setthawatcharawanich, et al.
Published: (2007-06-01)